Answers are grounded in this paper and cite their sources.
To develop and validate a pretreatment magnetic resonance imaging (MRI)-based 2.5D Transformer deep learning model for predicting metachronous liver metastasis (MLM) in patients with rectal cancer. This retrospective two-center study included 503 patients with pathologically confirmed rectal adenocarcinoma. Patients from Center A were divided into training and internal validation cohorts, while patients from Center B served as an external test cohort. Three 2.5D slice-selection strategies based on T2-weighted imaging were evaluated: axial three-slice, orthogonal maximum, and orthogonal central schemes. DenseNet-201 was used for deep feature extraction, and multiple fusion strategies were compared, including Transformer-based fusion. Independent clinical predictors were integrated with the optimal deep learning signature to construct a combined nomogram. Model performance was assessed using receiver operating characteristic (ROC) analysis, calibration curves, decision curve analysis (DCA), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). The orthogonal maximum strategy achieved the most stable performance among the slice-selection schemes. The Transformer model showed strong discrimination, with areas under the curve (AUCs) of 0.885, 0.864, and 0.858 in the training, internal validation, and external test cohorts, respectively. The combined model integrating the Transformer signature with MRI-reported extramural venous invasion (EMVI) and carbohydrate antigen 19 − 9 (CA19-9) yielded numerically higher AUCs of 0.903, 0.881, and 0.880 in the training, internal validation, and external test cohorts, respectively. The proposed 2.5D Transformer-based model may provide a non-invasive tool for individualized MLM risk stratification in rectal cancer.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: